推进针对GPCRs的调控性自身抗体的研究:第五届国际研讨会的见解
Otavio Cabral-Marques1, Lena F Schimke2, Guido Moll3
1Laboratory of Psychoneuroimmunology, Selye Lab, University of São Paulo School of Medicine, São Paulo, Brazil; Department of Medicine, Division of Molecular Medicine, Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, São Paulo, Brazil; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Sao Paulo, Brazil; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil; Interunit Postgraduate Program on Bioinformatics, Institute of Mathematics and Statistics, University of Sao Paulo, Sao Paulo, Brazil; D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
针对G蛋白结合受体 (RAB-GPCRs) 的调节性自身抗体是各种疾病的关键参与者. 研究表明RAB-GPCRs积极调节细胞信号,提供新的诊断和治疗机会.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 系统生物学 系统生物学
背景情况:
- 针对G蛋白结合受体 (RAB-GPCRs) 的自身抗体以前被视为被动性疾病标志物.
- 新兴证据突出显示RAB-GPCRs是关键细胞过程的活性调节者,包括信号传递,免疫调节和炎症.
研究的目的:
- 总结第五届RAB-GPCR国际研讨会的主要见解.
- 强调对RAB-GPCRs在各种人类病理中的作用的理解不断扩大.
- 讨论RAB-GPCRs作为生物标志物和治疗点的潜力.
主要方法:
- 在风湿病学,免疫学和神经病学专家之间进行跨学科讨论.
- 介绍了RAB-GPCRs选方法的进展.
- 分享新的生物标志物识别和治疗策略.
主要成果:
- RAB-GPCRs与自身免疫性疾病,心血管和脑血管疾病以及ME/CFS/PCS等神经免疫性疾病有关.
- 他们的参与扩展到固体器官和造血干细胞移植 (SOT/HSCT).
- RAB-GPCRs表现出与免疫媒介和非免疫媒介疾病相关的显著调节特性.
结论:
- 已知RAB-GPCRs是疾病发病的积极贡献者.
- 这些自身抗体作为诊断生物标志物和治疗点具有相当大的潜力.
- 预计对RAB-GPCRs的进一步研究将推动精准医学并改善临床结果.
更多相关视频
相关概念视频
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity


